Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Immune inflammatory biomarkers are easily obtained and inexpensive blood-based parameters that recently showed prognostic and predictive value in many solid tumors. In this study, we aimed to investigate the role of these biomarkers in predicting distant relapse in breast cancer patients treated wit...

Full description

Bibliographic Details
Main Authors: Marta Truffi, Federico Sottotetti, Nadav Gafni, Sara Albasini, Francesca Piccotti, Carlo Morasso, Valentina Tibollo, Michela Mocchi, Valentina Zanella, Fabio Corsi
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
inflammatory biomarkers
breast cancer care
neoadjuvant chemotherapy
blood count
prognostic factors
tailored therapy
Online Access:https://www.mdpi.com/2072-6694/14/21/5287

Internet

https://www.mdpi.com/2072-6694/14/21/5287

Similar Items